ry_sw01 cell injection
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 17, 2023 (NCT06058078)
Timeline
Indications
Mechanism of action
- Mesenchymal stem cellsImmunity, passive
Mesenchymal stem cells immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06489652 | Phase 1 | Jun 30, 2024 | Government of China |
| NCT06058091 | Phase 1/Phase 2 (Phase 2) | Sep 22, 2023 | Government of China, Nanjing University |
| NCT06058078 | Phase 2 | Aug 17, 2023 | Government of China, Nanjing University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 3 | 3 | 2 | 2023 |
| Nanjing University | Academic/Hospital | 2 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1